Graduated in Business Administration, BA, at the Athens’ American College of Greece.
Post-graduated in MBA, Finance at the University of Strathclyde in Glasgow, U.K.
Holds the position of Executive Vice President at RAFARM S.A., a leading pharmaceutical company based in Greece with related companies in Greece, UK and US.
Moreover, in 2016 he co-founded Aggrega Pharma, a company that is committed to building a selective, valuable pipeline of generic products by leveraging the vast R&D, clinical and manufacturing experience and capabilities of its members: Bluepharma (Portugal), RAFARM (Greece), Substipharm (France), Welding (Germany).
In 2023, he co-founded and assumed the role of CEO at BNS Ophthalmics (BNSO), a new Ophthalmic company that will develop, manufacture and commercialize a range of innovative pharmaceutical products, leveraging nanotechnology to address serious ophthalmic unmet needs for patients around the world.
Friday 12
12.20 - 12.55
The Greek Pharmaceutical Industry: Delivering Innovation
Ahrweiler Hall | European Cultural Centre of Delphi
Programming Partner: Panhellenic Union of Pharmaceutical Industries (PEF)